These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27521106)

  • 1. Never make assumptions: the complicated role of complement in urinary tract infections.
    Thurman JM; Nemenoff RA
    Kidney Int; 2016 Sep; 90(3):469-71. PubMed ID: 27521106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C5a receptor1 inhibition alleviates influenza virus-induced acute lung injury.
    Song N; Li P; Jiang Y; Sun H; Cui J; Zhao G; Li D; Guo Y; Chen Y; Gao J; Sun S; Zhou Y
    Int Immunopharmacol; 2018 Jun; 59():12-20. PubMed ID: 29621732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors.
    Colley CS; Popovic B; Sridharan S; Debreczeni JE; Hargeaves D; Fung M; An LL; Edwards B; Arnold J; England E; Eghobamien L; Sivars U; Flavell L; Renshaw J; Wickson K; Warrener P; Zha J; Bonnell J; Woods R; Wilkinson T; Dobson C; Vaughan TJ
    MAbs; 2018 Jan; 10(1):104-117. PubMed ID: 28952876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complement factor 5a receptor 1 has a pathogenic role in chronic inflammation and renal fibrosis in a murine model of chronic pyelonephritis.
    Choudhry N; Li K; Zhang T; Wu KY; Song Y; Farrar CA; Wang N; Liu CF; Peng Q; Wu W; Sacks SH; Zhou W
    Kidney Int; 2016 Sep; 90(3):540-54. PubMed ID: 27370410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement C5a Receptor 1 Exacerbates the Pathophysiology of
    Herrmann JB; Muenstermann M; Strobel L; Schubert-Unkmeir A; Woodruff TM; Gray-Owen SD; Klos A; Johswich KO
    mBio; 2018 Jan; 9(1):. PubMed ID: 29362231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting C5a: recent advances in drug discovery.
    Allegretti M; Moriconi A; Beccari AR; Di Bitondo R; Bizzarri C; Bertini R; Colotta F
    Curr Med Chem; 2005; 12(2):217-36. PubMed ID: 15638737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterisation of small molecule C5aR1 inhibitors in human cells reveals biased activities for signalling and function.
    Li XX; Lee JD; Massey NL; Guan C; Robertson AAB; Clark RJ; Woodruff TM
    Biochem Pharmacol; 2020 Oct; 180():114156. PubMed ID: 32682759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement Pathway.
    Anliker-Ort M; Dingemanse J; van den Anker J; Kaufmann P
    Front Immunol; 2020; 11():599417. PubMed ID: 33362783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease.
    Pandey MK; Burrow TA; Rani R; Martin LJ; Witte D; Setchell KD; Mckay MA; Magnusen AF; Zhang W; Liou B; Köhl J; Grabowski GA
    Nature; 2017 Mar; 543(7643):108-112. PubMed ID: 28225753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement C5aR1 Signaling Promotes Polarization and Proliferation of Embryonic Neural Progenitor Cells through PKCζ.
    Coulthard LG; Hawksworth OA; Li R; Balachandran A; Lee JD; Sepehrband F; Kurniawan N; Jeanes A; Simmons DG; Wolvetang E; Woodruff TM
    J Neurosci; 2017 May; 37(22):5395-5407. PubMed ID: 28455369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis.
    Carvelli J; Demaria O; Vély F; Batista L; Chouaki Benmansour N; Fares J; Carpentier S; Thibult ML; Morel A; Remark R; André P; Represa A; Piperoglou C; ; ; Cordier PY; Le Dault E; Guervilly C; Simeone P; Gainnier M; Morel Y; Ebbo M; Schleinitz N; Vivier E
    Nature; 2020 Dec; 588(7836):146-150. PubMed ID: 32726800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel interpretation of immune redundancy and duality in reperfusion injury with important implications for intervention in ischaemic disease.
    Thrane AS; Skehan JD; Thrane PS
    Med Hypotheses; 2007; 68(6):1363-70. PubMed ID: 17169498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C5a and pain development: An old molecule, a new target.
    Quadros AU; Cunha TM
    Pharmacol Res; 2016 Oct; 112():58-67. PubMed ID: 26855316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeutics.
    Ghosh M; Rana S
    Int Immunopharmacol; 2023 May; 118():110081. PubMed ID: 36989901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of the complement C5a receptor bound to the extra-helical antagonist NDT9513727.
    Robertson N; Rappas M; Doré AS; Brown J; Bottegoni G; Koglin M; Cansfield J; Jazayeri A; Cooke RM; Marshall FH
    Nature; 2018 Jan; 553(7686):111-114. PubMed ID: 29300009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental design of complement component 5a-induced acute lung injury (C5a-ALI): a role of CC-chemokine receptor type 5 during immune activation by anaphylatoxin.
    Russkamp NF; Ruemmler R; Roewe J; Moore BB; Ward PA; Bosmann M
    FASEB J; 2015 Sep; 29(9):3762-72. PubMed ID: 25999468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phagocytosis of live and dead Escherichia coli and Staphylococcus aureus in human whole blood is markedly reduced by combined inhibition of C5aR1 and CD14.
    Skjeflo EW; Christiansen D; Landsem A; Stenvik J; Woodruff TM; Espevik T; Nielsen EW; Mollnes TE
    Mol Immunol; 2019 Aug; 112():131-139. PubMed ID: 31102985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C5aR1 promotes acute pyelonephritis induced by uropathogenic E. coli.
    Li K; Wu KY; Wu W; Wang N; Zhang T; Choudhry N; Song Y; Farrar CA; Ma L; Wei LL; Duan ZY; Dong X; Liu EQ; Li ZF; Sacks SH; Zhou W
    JCI Insight; 2017 Dec; 2(24):. PubMed ID: 29263309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement cascade in severe forms of COVID-19: Recent advances in therapy.
    Chouaki Benmansour N; Carvelli J; Vivier E
    Eur J Immunol; 2021 Jul; 51(7):1652-1659. PubMed ID: 33738806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the antitumor immune response by complement.
    Markiewski MM; DeAngelis RA; Benencia F; Ricklin-Lichtsteiner SK; Koutoulaki A; Gerard C; Coukos G; Lambris JD
    Nat Immunol; 2008 Nov; 9(11):1225-35. PubMed ID: 18820683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.